From proposals to the sustainability of results, our mission is to reduce the burden for researchers and empower them to collaborate efficiently.
Munich, Germany
Joined February 2021
- Tweets82
- Following176
- Followers61
- Likes33
For this project on virtual twins we have helped writing the proposal back in early 2023. Max 6 of 65 submitted proposals have been selected for funding. This project made it.
#FraunhoferIZI launches #CERTAINTY with partners, pioneering #VirtualTwin for personalised cancer care. Focused on multiple myeloma, backed by €10M EU, this collaboration is set to transform CAR-T therapy & precision medicine.
👉 izi.fraunhofer.de/en/press/p…
#InnovativeOncology
Collaborate / Carl Steinbeisser retweeted
A snapshot from our Annual Hypermarker Meeting in Valencia. Big thanks to @incliva_iis for their hospitality!
#Hypermarker #AnnualMeeting #Valencia #Incliva
Collaborate / Carl Steinbeisser retweeted
November is prostate cancer awareness month.
Prostate cancer is more common than you may think, it is the most frequent cancer among males. This November take some time to learn and spread awareness about this all too common disease.
Collaborate / Carl Steinbeisser retweeted
#hiring ! 🎓 Our #PhDFellowship is pushing the boundaries of healthcare with cutting-edge AI and multiomics integration for hypertension treatment by patient's unique metabolomic profile. 🧬💊 Join us ! #AIHealthcare #HypertensionResearch #PersonalizedMedicine #Innovation
At our last PIONEER meeting, we showcased the outcomes of our three groundbreaking studyathons. These events brought together diverse experts, conducting data analysis across multiple international datasets.
One paper is already published. More to come!
Now at #ProstatePIONEER_GA23: B. De Meulder and R.Snijder chair the lessons learnt session from #PIONEER's 3️⃣ Studythons🙌
Questions adressed: long-term outcomes of patients on conserv. management, best treatment options and #AEs of systemic treatment in patients with mHSPCa .🩺
Collaborate / Carl Steinbeisser retweeted
Now at #ProstatePIONEER_GA23: B. De Meulder and R.Snijder chair the lessons learnt session from #PIONEER's 3️⃣ Studythons🙌
Questions adressed: long-term outcomes of patients on conserv. management, best treatment options and #AEs of systemic treatment in patients with mHSPCa .🩺
Collaborate / Carl Steinbeisser retweeted
A truly successfull meeting! 🤩 The final #ProstatePIONEER_GA23 has been officially closed by @NDowJames Project Coordinator and @Sevans_axelsson @EFPIA Project Lead 🎗️
We would like to thank everyone who contributed to this successful #GAM 🙏💙
Collaborate / Carl Steinbeisser retweeted
The 3rd #PIONEERStudyAThon23 was a great success! Main achievements: stable analytic platform set up (SAS Viya integrated & tested), study protocol refined, 2 R packages developed, new data sets identified on which study packages can be run, ideas for papers! Congratulations! 👏
ALT @Bertrand de Meulder, @Samu Kurki, @Ayman Hijazy, @James Brash, @Tom Abbott, @Daniel Kotik, @Robert Snijder, @ Andrew Chilelli, @Raivo Kolde, @Peter Prinsen, @Marek Oja, @Eleanor Davies, @ Daan Nieboer, @ Mitchell Conovor, @Ailbhe Lawlor, @Angelika Borkowetz, @Andreas Josefsson, @Jeremy Teoh, @Soundarya Palanisamy, @Qi Feng; @EFPIA; @ProstatePIONEER; @IMI_EHDEN
Collaborate / Carl Steinbeisser retweeted
Day 2 of #PIONEERStudyAThon_23 successfully came to an end! Results: 5 target cohorts and 21 wrapper #AdverseEvents cohorts were defined in ATLAS! 👏 The study protocol has been refined and will be presented next day. Congratulations! Keep it up! 👏
ALT @James Brush, @Samu Kirku, @Bertrand de Meulder, @Ayman Hijazy, @Daniel Kotik
We are incredibly proud to have consulted and co-written this research proposal for the funding programme HorizonEurope. It was positively evaluated, with a remarkable review of 15 out of 15 points. The project just started, so stay tuned for more news to come!
Hypermarker a #HorizonEurope project will unleash the potential of #pharmacometabolomics to develop and test new solutions for 'smart' prescriptions for #hypertension🩸💊
The proposal received a 10 million grant from #HorizonEurope and #UKResearchandInnovation & just started!
Collaborate / Carl Steinbeisser retweeted
Interested in results from our clinical patient preference study on Multiple #Myeloma? #PREFERlegacy
youtube.com/watch?v=a1ThMqz_…
Collaborate / Carl Steinbeisser retweeted
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research bmj.com/content/378/bmj-2021…
Collaborate / Carl Steinbeisser retweeted
Webinar invitation:
“Improving clinical research with routine health records – BigData@Heart” with Dipak Kotecha and Folkert Asselbergs.
11 January 2023, 11.30-12.30 CET
register here ->shorturl.at/mnFL8
Collaborate / Carl Steinbeisser retweeted
Interested in how we have been driving Study-a-Thons as a new paradigm to generate evidence with a dedicated highly focussed group of data partners, domain experts, data scientists, statistician, experts on guidelines?
lnkd.in/eNeMMUgR
Collaborate / Carl Steinbeisser retweeted
Want the full story behind the PREFER recommendations? Many of our reports on #PatientPreference methodology are available in full 👇
imi-prefer.eu/publications/d…
#PREFERCaseStudies #PREFERLeagacy
It's amazing the things that get accomplished when you lock a lot of data scientists, researchers, clinicians etc in a room for a week. From the 2 study-a-thons we helped organising we can tell it's fun. More in this recent publication
@OHDSI
@IMI_EHDEN
doi.org/10.1093/jamiaopen/oo…
Collaborate / Carl Steinbeisser retweeted
The best way to start #movember 1) trim your mustache 2) join an initiative to improve men health quality such as @ProstatePioneer #PIONEER_StudyAThon_22 RWD on mHSPC to predict outcomes in order to improve healthcare quality #prostatecancer @NDowJames @Sevans_axelsson @Uroweb
EQUATOR has now appraised our checklist and added CODE-EHR to their reporting database.
equator-network.org/reportin…
Must read: CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research academic.oup.com/eurheartj/a…
#EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes
Collaborate / Carl Steinbeisser retweeted
PREFER has issued recommendations on why, when and how to assess and use patient preferences in medical product decision-making.
Need a summary of the take-home messages? #PREFERlegacy 👇
youtu.be/xqJiAUC4eSg
Collaborate / Carl Steinbeisser retweeted
Must read: CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research academic.oup.com/eurheartj/a…
#EHJ #ESCCongress #ESCYoung @ehj_ed @rladeiraslopes